Literature DB >> 8041381

Botulinum toxin for spasmodic torticollis in a patient with myasthenia gravis.

J Emmerson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8041381     DOI： 10.1002/mds.870090319

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  6 in total

1.  Cervical Dystonia (Torticollis).

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-03       Impact factor: 3.598

2.  Subclinical myasthenia gravis causing increased sensitivity to botulinum toxin therapy.

Authors:  Dirk Dressler
Journal:  J Neural Transm (Vienna)       Date:  2010-10-16       Impact factor: 3.575

Review 3.  Cervical dystonia pathophysiology and treatment options.

Authors:  M Velickovic; R Benabou; M F Brin
Journal:  Drugs       Date:  2001       Impact factor: 9.546

4.  Cosmetic Injection of Botulinum Toxin Unmasking Subclinical Myasthenia Gravis: A Case Report and Literature Review.

Authors:  Grégory Timmermans; Frédérique Depierreux; François Wang; Isabelle Hansen; Pierre Maquet
Journal:  Case Rep Neurol       Date:  2019-08-16

5.  Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity.

Authors:  Dirk Dressler; Maria Concetta Altavista; Eckart Altenmueller; Roongroj Bhidayasiri; Saeed Bohlega; Pedro Chana; Tae Mo Chung; Carlo Colosimo; Klemens Fheodoroff; Pedro J Garcia-Ruiz; Beomseok Jeon; Lingjing Jin; Petr Kanovsky; Ivan Milanov; Federico Micheli; Olga Orlova; Sanjay Pandey; Zvezdan Pirtosek; Maja Relja; Raymond Rosales; José Alberto Sagástegui-Rodríguez; Gholam Ali Shahidi; Sofia Timerbaeva; Xinhua Wan; Uwe Walter; Fereshte Adib Saberi
Journal:  J Neural Transm (Vienna)       Date:  2021-02-26       Impact factor: 3.575

Review 6.  Contribution of Single-Fiber Evaluation on Monitoring Outcomes Following Injection of Botulinum Toxin-A: A Narrative Review of the Literature.

Authors:  Hélène Moron; Corine Gagnard-Landra; David Guiraud; Arnaud Dupeyron
Journal:  Toxins (Basel)       Date:  2021-05-17       Impact factor: 4.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.